Long-term Efficacy of Filgotinib Monotherapy and Combination Therapy: Interim Results from a Post Hoc Analysis of the FINCH 4 Study

被引：0

作者：

Buch, Maya H. ^{[1
,2
]}

Verschueren, Patrick ^{[3
,4
]}

Caporali, Roberto ^{[5
,6
]}

Huizinga, Thomas ^{[7
]}

Omoruyi, Edmund V. Ekoka ^{[8
]}

de Vries, Dick ^{[9
]}

Ritsema, Jeffrey ^{[10
]}

De Leonardis, Francesco ^{[11
]}

Aletaha, Daniel ^{[12
]}

机构：

[1] Univ Manchester, Div Musculoskeletal & Dermatol Sci, Manchester, Lancs, England

[2] NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England

[3] Univ Hosp Leuven, Dept Rheumatol, Leuven, Belgium

[4] Katholieke Univ Leuven, Leuven, Belgium

[5] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy

[6] ASST Gaetano Pini CTO, Dept Rheumatol & Med Sci, Milan, Italy

[7] Leiden Univ, Dept Rheumatol, Leiden, Netherlands

[8] Galapagos NV, Biostat, Mechelen, Belgium

[9] Galapagos BV, Clin Dev, Leiden, Netherlands

[10] Galapagos BV, Med Affairs, Leiden, Netherlands

[11] Galapagos GmbH, Med Affairs, Basel, Switzerland

[12] Med Univ Vienna, Div Rheumatol, Dept Med 3, Vienna, Austria

来源：

ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2252

引用

页码：4531 / 4534

页数：4

共 50 条

[31] Safety and efficacy of filgotinib in patients with rheumatoid arthritis: final results of the DARWIN 3 long-term extension study
Westhovens, Rene
Winthrop, Kevin L.
Kavanaugh, Arthur
Greenwald, Maria
Dagna, Lorenzo
Cseuz, Regina
Besuyen, Robin
de Vries, Dick
Modgill, Vikas
Le, Ly Huong
Genovese, Mark C.
Emery, Paul
Verschueren, Patrick
Alten, Rieke
RMD OPEN, 2025, 11 (01):
[32] ABP 501 Long-Term Safety/Efficacy: Interim Results from an Open-Label Extension Study
Cohen, Stanley
Pablos, Jose L.
Zhang, Nan
Rizzo, Warren
Muller, Gerhard
Padmanaban, Devi
Kivitz, Alan
Matsumoto, Alan K.
Kaur, Primal
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[33] Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3
Aletaha, Daniel
Westhovens, Rene
Gaujoux-Viala, Cecile
Adami, Giovanni
Matsumoto, Alan
Bird, Paul
Messina, Osvaldo Daniel
Buch, Maya H.
Bartok, Beatrix
Yin, Zhaoyu
Guo, Ying
Hendrikx, Thijs
Burmester, Gerd R.
RMD OPEN, 2021, 7 (02):
[34] Long-term Efficacy with Sitagliptin as Monotherapy or Add-on Therapy to Metformin
不详
PHYSICIAN AND SPORTSMEDICINE, 2009, 37 (02) : 9 - 9
[35] Long-term efficacy and tolerability of telmisartan as monotherapy and in combination with other antihypertensive medications
Neutel, JM
Klein, C
Meinicke, TW
Schumacher, H
BLOOD PRESSURE, 2002, 11 (05) : 302 - 309
[36] Post hoc Analysis of Long-term Efficacy of Brodalumab in Early vs Late Responders With Psoriasis
Lebwohl, Mark
Han, George
Svidzinski, Cula
Jacobson, Abby
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB209 - AB209
[37] Long-term efficacy and safety with zonisamide: Interim analysis of an open-label study
Wroe, S
Brodie, MJ
EPILEPSIA, 2005, 46 : 118 - 118
[38] LACOSAMIDE MONOTHERAPY IN PATIENTS WITH EPILEPSY PREVIOUSLY TREATED WITH A COMBINATION THERAPY: INTERIM RESULTS OF AN OBSERVATIONAL STUDY
Cumbo, E.
Ligori, L. D.
EPILEPSIA, 2014, 55 : 117 - 117
[39] Long-term safety and efficacy of subcutaneous pasireotide in patients with Cushing’s disease: interim results from a long-term real-world evidence study
Luca Manetti
Timo Deutschbein
Jochen Schopohl
Kevin C. J. Yuen
Michael Roughton
Ulrike Kriemler-Krahn
Libuse Tauchmanova
Ricardo Maamari
Carla Giordano
Pituitary, 2019, 22 : 542 - 551
[40] Long-term safety and efficacy of subcutaneous pasireotide in patients with Cushing's disease: interim results from a long-term real-world evidence study
Manetti, Luca
Deutschbein, Timo
Schopohl, Jochen
Yuen, Kevin C. J.
Roughton, Michael
Kriemler-Krahn, Ulrike
Tauchmanova, Libuse
Maamari, Ricardo
Giordano, Carla
PITUITARY, 2019, 22 (05) : 542 - 551

← 1 2 3 4 5 →